Study guide
6.3 Non-Ischemic Stress Echo and Hemodynamic Provocation
CCI Registered Cardiac Sonographer RCS
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: RCS Orientation and Clinical Context
1.1 RCS Identity, Exam Format, Application, and Retesting 1.2 Clinical History, Symptoms, Indications, and Risk Factors 1.3 Prior Studies, Serial Change, and Cross-Modality Context
2 Chapter 2: Orders, Safety, and Patient Preparation
2.1 Order Verification, Scope, and Protocol Selection 2.2 Sonographer Ergonomics and Staff Safety 2.3 Patient Preparation, Positioning, Consent, Infection Control, and Aftercare
3 Chapter 3: Reporting and 2-D TTE Foundations
3.1 Structured Findings, Significant Results, and Escalation 3.2 Standard 2-D TTE Windows, Views, and Acquisition Sequence 3.3 2-D Measurements, Foreshortening, Image Quality, and QA
4 Chapter 4: M-Mode and Doppler Acquisition
4.1 M-Mode Alignment, Timing, Measurements, and Pitfalls 4.2 Color Doppler Acquisition, Scale, Gain, and Jet Display 4.3 PW and CW Spectral Doppler Acquisition
5 Chapter 5: Advanced Doppler and Contrast
5.1 Tissue Doppler and Hemodynamic Sample Placement 5.2 Ultrasound-Enhancing Agents and LV Opacification 5.3 Agitated-Saline Studies and Intracardiac Shunts
6 Chapter 6: Stress Echocardiography
6.1 Exercise Stress Echo Protocols and Peak Imaging 6.2 Pharmacologic Stress Echo, Dobutamine, and Safety 6.3 Non-Ischemic Stress Echo and Hemodynamic Provocation
7 Chapter 7: TEE, Strain, and 3-D TEE
7.1 Assisting TEE: Preparation, Probe Safety, Views, and Complications 7.2 Strain Acquisition, Tracking Quality, and Reproducibility 7.3 3-D TEE Acquisition, Cropping, Orientation, and Artifacts
8 Chapter 8: 3-D TTE and the Aortic Valve
8.1 3-D TTE Full-Volume Acquisition and Quantitation 8.2 Aortic-Valve Anatomy, Morphology, and Function 8.3 Aortic Stenosis: Velocities, Gradients, Valve Area, and Flow States
9 Chapter 9: Aortic Regurgitation and Mitral Structure
9.1 Aortic Regurgitation Mechanisms and Integrated Severity 9.2 Mitral-Valve Anatomy, Motion, and Mechanisms 9.3 Mitral Stenosis: Planimetry, Gradients, Pressure Half-Time, and Suitability
10 Chapter 10: Mitral and Tricuspid Valve Findings
10.1 Mitral Regurgitation Mechanism, Quantitation, and Severity Integration 10.2 Tricuspid-Valve Anatomy, Structure, and Function 10.3 Tricuspid Stenosis Assessment
11 Chapter 11: Right-Sided Valve Disease
11.1 Tricuspid Regurgitation Mechanism and Severity 11.2 Pulmonic-Valve Anatomy, Structure, and Function 11.3 Pulmonic Stenosis Assessment
12 Chapter 12: Pulmonic Regurgitation and Prosthetic Valves
12.1 Pulmonic Regurgitation Mechanism and Severity 12.2 Normal Mechanical and Bioprosthetic Valve Assessment 12.3 Prosthetic Obstruction, Regurgitation, Thrombosis, and Patient–Prosthesis Mismatch
13 Chapter 13: Endocarditis and Cardiac Chambers
13.1 Valvular Endocarditis, Vegetations, Abscess, and Complications 13.2 LV and LA Size, Geometry, Volumes, Mass, and Function 13.3 RV and RA Size, Pressure, Volume, and Function
14 Chapter 14: Cardiomyopathy Phenotypes and Diastology
14.1 Dilated and Hypertrophic Cardiomyopathies, SAM, and LVOT Obstruction 14.2 Restrictive, Arrhythmogenic, and Stress Cardiomyopathies 14.3 Diastolic Function, Filling Pressure, Grading, and Pitfalls
15 Chapter 15: Systolic Function and Ischemia
15.1 LV Systolic Function, Simpson EF, Regional Motion, and Output 15.2 RV Systolic Function: TAPSE, S-prime, FAC, and Coupling 15.3 Ischemic Heart Disease, Coronary Territories, Stress Response, and Complications
16 Chapter 16: Pericardium and Great Vessels
16.1 Pericardial Effusion, Tamponade, Constriction, and Doppler Physiology 16.2 Great Vessels, Venous Return, and Pulmonary Artery Assessment 16.3 Aortic Root, Aneurysm, Dissection, and Coarctation
17 Chapter 17: Pulmonary Pressure, Masses, and Congenital Recognition
17.1 Pulmonary Hypertension, RAP/PASP Estimation, and RV Consequences 17.2 Cardiac Masses, Thrombus, Tumor, Vegetation, and Mimics 17.3 Adult Recognition of ASD, VSD, PFO, PDA, and Congenital Clues
18 Chapter 18: Devices, Strain, and Hemodynamics
18.1 ICDs, Pacemakers, Occluders, Closure Devices, and Mechanical Support 18.2 Strain Interpretation, Global Longitudinal Strain, and Disease Patterns 18.3 Cardiac Hemodynamics, Bernoulli, Continuity, Stroke Volume, and Shunts
19 Chapter 19: Infiltrative Disease and Physics Foundations
19.1 Amyloid, Sarcoid, and Other Infiltrative Disease Patterns 19.2 Ultrasound Wave Properties, Propagation, Frequency, and Wavelength 19.3 Artifact Recognition: Reverberation, Shadowing, Mirror, Refraction, and Aliasing
20 Chapter 20: Resolution and Doppler Optimization
20.1 Axial/Lateral Resolution, Frame Rate, Depth, Focus, and Trade-Offs 20.2 Spectral Doppler Optimization, Nyquist, Filters, Gain, and Angle 20.3 Color Doppler Optimization, Scale, Priority, Variance, and Gain
21 Chapter 21: 2-D, 3-D, and Contrast Optimization
21.1 2-D Optimization: Frequency, Gain, TGC, Harmonics, Depth, and Focus 21.2 3-D Optimization: Volume Rate, Stitching, Cropping, and Display 21.3 Contrast Optimization: Mechanical Index, Destruction, Replenishment, and Artifacts
6.3 Non-Ischemic Stress Echo and Hemodynamic Provocation
Key Takeaways Explain This Topic AI
Non-ischemic stress echocardiography targets a prespecified physiologic question such as filling-pressure response, dynamic LVOT obstruction, valve gradients, regurgitation, pulmonary pressure, or ventricular reserve.
Exercise—especially supine bicycle—is often preferred when stage-specific Doppler is needed, while dobutamine is reserved for selected contractile- or flow-reserve questions rather than used as a universal substitute.
Prioritize measurements that can disappear at peak, preserve workload, HR, BP, symptoms, rhythm, position, and maneuver, and compare identical sites and settings across stages.
Provocative maneuvers alter preload or afterload and must be performed exactly as ordered and supervised; the sonographer should not improvise a stronger provocation.
Distinguish LVOT, mitral-regurgitation, valve, and TR signals before tracing, and immediately escalate concerning symptoms, gradients, rhythms, or hemodynamic responses.
Last updated: July 2026
Start with the physiologic question
CCI task B9 is to perform non-ischemic stress echocardiography. Unlike a standard ischemia study centered on regional wall motion, this examination may ask why exertional dyspnea occurs, whether an LV outflow tract (LVOT) gradient is provocable, whether a valve gradient or regurgitant lesion becomes important with flow, whether pulmonary pressure rises with symptoms, or whether a ventricle has contractile reserve. The team cannot acquire every possible variable at peak. Before stress, confirm the ordered question, stressor, stages, priority measurements, termination plan, and who supervises each maneuver.
Exercise is the preferred stressor for many non-ischemic questions because symptoms and hemodynamics occur under physiologic load. Supine or semi-supine bicycle exercise is especially useful because Doppler can be acquired at baseline, low workload, peak, and recovery. Treadmill testing may be appropriate, but transient Doppler findings can fade during transfer. Dobutamine is useful for selected contractile- or flow-reserve questions, including some low-flow valve evaluations; it is not a physiologic replacement for every exercise question. The supervising clinician chooses the stressor.
Clinical question Priority acquisition Technical risk to control
Unexplained exertional dyspnea/HFpEF Mitral inflow, annular e-prime, TR velocity, HR, BP, symptoms E/A fusion, poor TR envelope, changing sample site
Dynamic HCM obstruction LVOT color and CW Doppler, MR color/CW, symptoms and BP Mixing LVOT and MR envelopes; nonparallel beam
Valve or prosthesis under flow Matched PW/CW gradients, regurgitation, stroke-volume data Comparing different sites, settings, rhythms, or workloads
Pulmonary/RV response TR CW, RV size/function views, workload and oxygen data when ordered Assuming pressure from an incomplete TR envelope
Contractile reserve Matched LV or RV views and ordered flow measures Foreshortening or comparing unmatched stages
Diastolic and pulmonary hemodynamic stress
The 2025 ASE diastolic guideline recommends diastolic exercise echocardiography in selected symptomatic patients when estimated left-atrial pressure is normal at rest but HFpEF remains suspected. Acquire an excellent apical four-chamber view before exercise and retain mitral E and A, septal and lateral tissue Doppler e-prime as ordered, TR peak velocity, and stage-specific HR and BP. During bicycle stress, collect priority Doppler at lower workloads before E and A fuse; repeat at recovery if peak tachycardia prevents measurement. A ratio or velocity is not interpretable when the sample volume moved, the envelope is incomplete, or different beats and stages are mixed.
A rise in TR velocity during exercise reflects both flow and pressure and must be considered with age, workload, right-heart response, and signal quality. Current right-heart guidance cautions against treating one exercise pulmonary-pressure number as universally abnormal. Trace only a complete, well-aligned envelope and document when no reliable signal exists. Do not inject an enhancing agent for a weak TR signal or change oxygen solely to obtain a number unless an authorized protocol specifically directs it. Symptoms, workload, BP, and oxygen saturation when ordered remain part of the physiologic story.
Dynamic obstruction and valve provocation
For hypertrophic cardiomyopathy, provocation can include Valsalva, standing, squat-to-stand, or exercise. These maneuvers change preload and afterload differently. Obtain resting anatomy, color localization, and LVOT PW mapping before CW. During each ordered maneuver, align through the LVOT and label the exact position and stage. A dynamic LVOT envelope often peaks late in systole. Mitral-regurgitation velocity may be higher, begin earlier, and contaminate the same CW line; use color direction, PW mapping, waveform timing, multiple windows, and audible/visual signal characteristics to separate them. Tracing MR as LVOT can grossly overstate the gradient.
Exercise is the physiologic method to provoke latent LVOTO; the 2022 ASE multimodality HCM guideline does not recommend dobutamine for this purpose because it can create dynamic gradients even in people without HCM. The sonographer must not improvise a Valsalva, dehydration, medication change, or more forceful maneuver. Confirm that the clinician wants the maneuver, coach it consistently, and stop coaching if symptoms or instability develops. The supervising clinician determines whether a gradient is meaningful and whether testing should continue.
Valve stress likewise requires matched data. A mitral-stenosis study may prioritize transmitral mean gradient and TR velocity at baseline, low workload, and peak. A prosthetic-valve study may compare gradients and effective flow response. In low-flow, low-gradient aortic stenosis, low-dose dobutamine may assess flow reserve and changing valve hemodynamics. Keep PW sample level, CW window, gain, sweep speed, averaging method, and stage labels consistent; never compare a rest apical envelope with a peak right-parasternal envelope without identifying the change. Interpretation uses the full disease-specific guideline, not an isolated peak gradient.
Safety and handoff
Non-ischemic does not mean low risk. Severe dyspnea, chest pain, presyncope, hypotension, extreme hypertension, sustained arrhythmia, desaturation, a rapidly rising gradient with symptoms, or right-ventricular deterioration requires immediate communication. The sonographer reports observable facts and captures supporting data only if doing so does not delay care. The authorized clinician decides termination and treatment; an immediate threat triggers the emergency response.
At completion, verify that every saved loop and Doppler envelope names the stage, workload or maneuver, position, HR, BP, rhythm, and relevant symptoms. Report incomplete targets rather than filling gaps with a later stage. A focused, reproducible dataset answers the question better than an impressive collection of unlabeled peak signals.